C. elegans: a model organism
C. elegans is a small, transparent, free living soil nematode that is used as a model organism for the study of several cellular/developmental processes. Many unique elements contribute to the power of this system including the full description of its embryonic and postembryonic cell lineage, the arsenal of molecular tools, and the ability to harness RNAi for full genome surveys of gene function.
Control of germ line quiescence
During suboptimal growing conditions, C. elegans can enter a developmentally-arrested stage known as dauer that is specialized for dispersal and survival. Three independent signalling pathways (insulin-like, TGF-β, and cGMP) control entry into this stage and subsequently affect the changes that will occur in morphology, physiology, and behaviour. One of these changes is the establishment of cell cycle quiescence within every tissue of the animal.
To understand how this quiescence is established during dauer in the germ line stem cells, we performed a screen for dauer-specific germ line hyperplasia and isolated aak-2 and par-4 alleles that correspond to the mammalian genes AMPK and LKB1 (an AMPK activator). LKB1 mutations in humans are associated with Peutz-Jeghers syndrome, which predisposes afflicted individuals to various cancers.
Click here for more information...We found that AMPK loss-of-function is not fully responsible for the LKB1 phenotype, implying that par-4/LKB1 has other unknown targets that may play roles in cancer development. A subsequent genetic screen confirmed that other AMPK subunits and LKB1-associated proteins are critical for germ line quiescence. We have also isolated several other mutations in the laboratory which phenocopy aak-2 and par-4. Cloning of these alleles should ultimately identify downstream targets of the AMPK and LKB1 complexes that may provide further insight concerning the mechanisms through which insulin signalling mediates cell growth and cancer onset.
Coupling the cell cycle with the centrosome cycle
Sexually reproducing organisms must eliminate a pair of centrioles prior to the first zygotic division to avoid the formation of a multipolar spindle. During the development of the C. elegans germline, this process requires the activity of the p21/p27-like CDK inhibitor protein cki-2. cki-2 is presumably required to block CDK activity during the onset of oogenesis. In addition to oocyte-specific elimination of the centrosome, we are examining various developmental contexts exist where centrosome duplication must diverge from the intimate coupling of the centrosome cycle with the cell cycle.
Click here for more information...By monitoring centrosome dynamics in contexts where cells undergo alternative cell cycles we hope to determine how the centrosome cycle adapts to these variations. In C. elegans, the intestinal and some hypodermal cells undergo endoreduplication during postembryonic development. We generated a centriolar GFP reporter to detect the presence of centrosomes in these tissues and are currently verifying the effects of various genes on this process.
Understanding endocycles
The precise spatiotemporal coordination between developmental pathways and the cell cycle machinery is essential to ensure timely and accurate progression through the cell division cycle together with controlled growth and differentiation of cells and organs.
The intestinal cells of C. elegans undergo three types of developmentally-regulated cell cycles: mitosis during embryogenesis, then karyokinesis (nuclear division without karyokinesis) and endocycles postembryonically. Thus, this organ provides a unique and powerful model system to study the regulation of these distinct cell cycles in a developmental context and to discover the molecular signals controlling the transitions between them.
Click here for more information...Endocycles are very specialized in that successive S-phases proceed without intervening mitosis, enabling these cells to bypass the mitotic checkpoints and grow without undergoing cell division. To uncover the regulatory mechanisms underlying such checkpoint relaxation, we designed a feeding RNAi-based genetic screen to identify genes that affect endocycle timing or execution in the intestine of C. elegans. Feeding these animals with dsRNA-producing clones allows us to discover novel genes that act in the intestine to control the endocycles, without adverse effects on other tissues. Our strategy provides a novel and efficient method to identify tissue-specific functions of essential regulatory genes that would have been impossible to detect by classical genetic approaches.
